A permanent medical history exhibition at the Berlin-based Max Delbrück Center for Molecular Medicine (MDC) impressively shows that microscopes have always been part of medical advances. Manufacturers and scientists in Berlin and Brandenburg have…
The Helmholtz Association is strengthening collaborative research in Europe – especially in Eastern, Central, and Southern Europe – through its new "Helmholtz European Partnering" funding program. The institutional partnership with a Helmholtz Center…
Scientists at the Berlin-Brandenburg Center for Regenerative Therapies (BCRT) of the Charité – Universitätsmedizin Berlin and the Fraunhofer-Institute for Cell Therapy and Immunology have received the manufacturing authorization for their CardAP…
Obesity is associated with adipose tissue inflammation, insulin resistance and the development of type 2 diabetes (T2D). However, our understanding is mostly based on conventional murine models and promising preclinical studies rarely translated into…
Humedics GmbH, a specialist in real-time measurement of liver function capacity, announced results of a multicenter randomized controlled clinical trial that clearly shows the benefits of the LiMAx® test in liver surgery. Perioperative use of the…
According to initial analyses, the business development of the Berlin based isotope specialists Eckert & Ziegler Strahlen- und Medizintechnik AG (ISIN DE0005659700) was significantly higher as of June 30, 2018 than the comparable value of the prior…
After a successful cooperation in 2017, the Berlin Institute of Health (BIH) is working together with the accelerator program Startupbootcamp Digital Health Berlin again this year. The program supports ten international start-ups annually. The aim is…
Startupbootcamp announces 12 startups from 8 different countries invited to join the 2018 Digital Health accelerator program in Berlin
Researchers from Charité – Universitätsmedizin Berlin have shown that antibiotics can increase the risk of some types of pneumonia by weakening the lung’s immune system. Findings suggest that this risk may be reduced through the administration of…
German diagnostics company sphingotec GmbH (Hennigsdorf) and Nexus Dx (San Diego) have combined their technology platforms to market sphingotec’s CE-marked acute biomarkers penKid® and bio-ADM® on Nexus’ market-validated POC testing immunoassay…
